Saturday, October 3, 2026

Copper Futures Jumps By 7% In The Last 10 Sessions

Copper Futures Jumps By 7% In The Last 10 Sessions

(VIANEWS) - Copper (HG) has been up by 7.65% for the last 10 sessions. At 11:50 EST on Monday, 18 March, Copper (HG) is $4.15.

Volume

Today's last reported volume for Copper is 80456, 99.99% below its average volume of 10377893780.59.

Volatility

Copper's last week, last month's, and last quarter's current intraday variation average was 0.05%, 0.25%, and 0.82%, respectively.

Copper's highest amplitude of average volatility was 0.41% (last week), 0.68% (last month), and 0.82% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Copper's commodity is considered to be oversold (<=20).

News about

  • WTI crude oil weekly forecast: higher sustained prices developing strength - 17 March 2024. According to DailyForex on Sunday, 17 March, "The ability of WTI Crude Oil to start marching upwards on Wednesday and then reach velocity on Thursday is noteworthy, particularly because the commodity held onto its momentum on Friday and finished the week near its highs.WTI Crude Oil Trend and Coming Tests this Week", "While the bearish trend was occurring it should be noted on the 5th of October WTI Crude Oil was trading around the 82.000 ratio. "
  • According to FXStreet on Monday, 18 March, "West Texas Intermediate (WTI) US Crude Oil prices build on last week's strong gains of nearly 4% and gain some follow-through positive traction on Monday. ", "Nevertheless, the aforementioned fundamental backdrop favours bullish traders and suggests that the path of least resistance for Crude Oil prices remains to the upside. "

More news about Copper (HG).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com